B-NEOCEPT 30

Agglutination Method, Human Chorionic Gonadotropin

ORGANON, INC.

The following data is part of a premarket notification filed by Organon, Inc. with the FDA for B-neocept 30.

Pre-market Notification Details

Device IDK840650
510k NumberK840650
Device Name:B-NEOCEPT 30
ClassificationAgglutination Method, Human Chorionic Gonadotropin
Applicant ORGANON, INC. 4221 Richmond Rd., N.W. Walker,  MI  49534
Product CodeJHJ  
CFR Regulation Number862.1155 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1984-02-15
Decision Date1984-04-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.